Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study

NCT: NCT07286890 · RECRUITING

NCT IDNCT07286890
StatusRECRUITING
Start Date2026-03-04
Completion2026-12
SponsorMaquet Cardiovascular (INDUSTRY)
First posted
Last updated

Brief Summary

This observational study aims to collect data on the performance and safety of Getinge's Beating Heart products used during open-heart coronary artery bypass graft surgery. The surgery and the use of the study devices will be done according to the standard of care. Participants will not be required to undergo any study-specific procedures, and information will be collected only until hospital discharge following the surgery.

Frequently Asked Questions

What is Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study?

Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study is a clinical trial registered under NCT07286890. Current status: RECRUITING.

What is the status of NCT07286890?

The current status of NCT07286890 (Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study) is: RECRUITING.

When did Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study start?

Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study started on 2026-03-04.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.